Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2

EU orphan designation number: EU/3/09/638   
Active ingredient: Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2
Indication: Prevention of the ischaemia/reperfusion injury associated with solid organ transplantation
Sponsor: Opsona Therapeutics Limited
2nd floor, Ashford House, Tara Street, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Orphan designation EMEA/OD/119/08 (2009)4055 of 15/05/2009
14/09/2012 Change of name and/or address of sponsor EMEA/OD/119/08